|
|
Approval
Once FDA approves an NDA, the new medicine becomes available for
physicians to prescribe. A company must continue to submit periodic
reports to FDA, including any cases of adverse reactions and appropriate
quality-control records. For some medicines, FDA requires additional
trials (Phase IV)
to evaluate long-term effects.
|
